Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
Public ClinicalTrials.gov record NCT02390531. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02390531
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Jaeb Center for Health Research
- Other
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Bevacizumab Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 6 Months
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 27, 2015
- Primary completion
- Jun 3, 2019
- Completion
- May 10, 2021
- Last update posted
- Nov 2, 2022
2015 – 2021
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Emory Eye Center | Atlanta | Georgia | 30322 | — |
| Riley Hospital for Children | Indianapolis | Indiana | 46202 | — |
| Wilmer Institute | Baltimore | Maryland | 21287 | — |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | — |
| Duke University Eye Center | Durham | North Carolina | 27710 | — |
| Cincinnati Children's Hospital | Cincinnati | Ohio | 45229 | — |
| Pediatric Ophthalmology Associates, Inc. | Columbus | Ohio | 43205 | — |
| Dean A. McGee Eye Institute, University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| Texas Children's Hospital - Dept. Of Ophthalmology | Houston | Texas | 77030 | — |
| University of Utah Moran Eye Center | Salt Lake City | Utah | 84132 | — |
| Virginia Pediatric Eye Center | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02390531, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02390531 live on ClinicalTrials.gov.